Clinical Trials in Arizona

Showing 1081-1100 of 16,770 trials

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

NCT04691154

This Phase 3, 2-part, open-label, multicenter study aims to demonstrate the safety and tolerability of L606 in patients with PAH or PH-ILD. The study will determine the short-term and long-term safety and tolerability of L606 in this patient population.

Pulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases

Liquidia Technologies, Inc.28 participantsStarted Aug 2021

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +5 more locations

COMPLETEDPhase 231 miles

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

NCT04129931

The primary objective of this study is to evaluate several interventions given to participants with severe asthma. Interventions are administered in a crossover manner with 16-week treatment periods followed by 8 to 16 week washout.

Asthma

University of North Carolina, Chapel Hill950 participantsStarted Dec 2019

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Sacramento, California, United States +26 more locations

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Find Trials by Condition in Arizona

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Avapritinib With Decitabine in Patients With SM-AHN

ETNA-MS Device Validation Study

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Acupressure in Patients With Sickle Cell Disease

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia

Open-label Extension Study of Brazikumab in Crohn's Disease

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Using Aspirin to Improve Immunological Features of Ovarian Tumors